EGFR inhibitor 57   Click here for help

GtoPdb Ligand ID: 12278

Compound class: Synthetic organic
Comment: This compound is an experimental allosteric inhibitor of EGFRL858R [1]. It was designed for potential to overcome EGFRC797S-mediated resistance in non-small-cell lung cancers that are positive for the activating EGFRL858R mutation.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 9
Topological polar surface area 129.34
Molecular weight 681.27
XLogP 5.68
No. Lipinski's rules broken 1
Click here for help
Canonical SMILES OCC1CCN(CC1)Cc1ccc(cc1)C#Cc1cc(C(F)F)c2c(c1C)nn(c2)C(c1ncn2c1CCC12CC1)C(=O)Nc1nccs1
Isomeric SMILES FC(F)c1c2cn(nc2c(c(c1)C#Cc1ccc(cc1)CN1CCC(CC1)CO)C)C(c1ncn2c1CCC12CC1)C(=O)Nc1sccn1
InChI InChI=1S/C37H37F2N7O2S/c1-23-27(7-6-24-2-4-25(5-3-24)19-44-15-9-26(21-47)10-16-44)18-28(34(38)39)29-20-46(43-31(23)29)33(35(48)42-36-40-14-17-49-36)32-30-8-11-37(12-13-37)45(30)22-41-32/h2-5,14,17-18,20,22,26,33-34,47H,8-13,15-16,19,21H2,1H3,(H,40,42,48)
Bioactivity Comments
Orally-dosed inhibitor 57 promotes tumour regression in an EGFRL858R/C797S tumour xenograft model [1].
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
epidermal growth factor receptor Hs Allosteric modulator Inhibition 7.7 – 8.7 pIC50 - 1
pIC50 8.7 (IC50 2x10-9 M) [1]
Description: Inhibition potency for EGFR with the L858R/T790M/C797S triple mutation.
pIC50 7.7 (IC50 2x10-8 M) [1]
Description: Inhibition potency for EGFR with the L858R/C797S double mutation